| Model Number |
VNMF4040C62TU |
| Medical Device Problem Code |
Leak/Splash (1354)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/23/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Concomitant medical products: other relevant device(s) are: product id: v nmf4040c62tu, serial/lot #: (b)(4), ubd: 23-sep-2020, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Valiant navion stent grafts were implanted during an endovascular procedure for the treatment of a thoracic aortic aneurysm. it was reported from a ct taken that a type i endoleak from the aortic neck and type ii endoleak from a patent lumbar vessel were observed. no cause of the type ia endoleak was provided. no additional clinical sequelae was provided and the patient will be monitored.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information received: it was confirmed the patient also has an endurarnt etbf3620c145e ( sn (b)(6) ) implanted on 16-jan-2019 and the type ia endoleak was see in the 2 navion grafts (vnmf4040c62tu ((b)(6) ) <(>&<)> vnmf4040c62tu ( sn (b)(6) ) and the endurant bifurcate.Per the physician the cause of the type ia endoleak is undetermined.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|